Cargando…

Assessment of compounded transdermal mirtazapine as an appetite stimulant in cats with chronic kidney disease

OBJECTIVES: The aim of this study was to assess the appetite stimulation properties of compounded transdermal mirtazapine (CTM) in cats with chronic kidney disease (CKD). METHODS: Two sequential double-blind placebo-controlled crossover prospective studies were performed in client-owned cats with st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quimby, Jessica M, Benson, Kellyi K, Summers, Stacie C, Saffire, Ashlie, Herndon, Andrea K, Bai, Shasha, Gustafson, Daniel L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099811/ https://www.ncbi.nlm.nih.gov/pubmed/31161850 http://dx.doi.org/10.1177/1098612X19851303

Ejemplares similares

In vivo and in vitro assessment of mirtazapine pharmacokinetics in cats with liver disease
por: Fitzpatrick, Rikki L., et al.
Publicado: (2018)

Appetite Stimulant and Anti-Emetic Effect of Mirtazapine Transdermal Ointment in Cats Affected by Lymphoma Following Chemotherapy Administration: A Multi-Centre Retrospective Study
por: Ferro, Livia, et al.
Publicado: (2022)

A double‐blind, placebo‐controlled, randomized study to evaluate the weight gain drug, mirtazapine transdermal ointment, in cats with unintended weight loss
por: Poole, Melinda, et al.
Publicado: (2018)

The fecal microbiome and serum concentrations of indoxyl sulfate and p‐cresol sulfate in cats with chronic kidney disease
por: Summers, Stacie C., et al.
Publicado: (2018)

Serum concentrations of gabapentin in cats with chronic kidney disease
por: Quimby, Jessica M, et al.
Publicado: (2022)

Serum and Fecal Amino Acid Profiles in Cats with Chronic Kidney Disease
por: Summers, Stacie C., et al.
Publicado: (2022)

Measurement of Ghrelin as a Marker of Appetite Dysregulation in Cats with and without Chronic Kidney Disease
por: Brusach, Katelyn, et al.
Publicado: (2023)

The Effect of Dietary Protein Concentration on the Fecal Microbiome and Serum Concentrations of Gut-Derived Uremic Toxins in Healthy Adult Cats
por: Summers, Stacie, et al.
Publicado: (2023)

Extranodal non-B, non-T-cell lymphoma with bilateral tympanic bulla involvement in a cat
por: Kerns, Austin T, et al.
Publicado: (2018)

Appetite‐stimulating effects of once‐daily omeprazole in cats with chronic kidney disease: Double‐blind, placebo‐controlled, randomized, crossover trial
por: Spencer, Ashley, et al.
Publicado: (2021)

Biological variation of major gut‐derived uremic toxins in the serum of healthy adult cats
por: Summers, Stacie, et al.
Publicado: (2021)

Mirtazapine for Refractory Gastroparesis
por: Marella, Hemnishil K., et al.
Publicado: (2019)

Preliminary evaluation of fecal fatty acid concentrations in cats with chronic kidney disease and correlation with indoxyl sulfate and p‐cresol sulfate
por: Summers, Stacie, et al.
Publicado: (2019)

To Stimulate Appetite
Publicado: (1892)

The cat with weight loss and a good appetite
por: Gunn-Moore, Danièlle, et al.
Publicado: (2006)

Transdermal Absorption of Methimazole- a Cat’s Tale
por: Mittal, Ashima, et al.
Publicado: (2021)

A pilot study of transdermal gabapentin in cats
por: Slovak, Jennifer E., et al.
Publicado: (2021)

Stimulants for the Control of Hedonic Appetite
por: Poulton, Alison S., et al.
Publicado: (2016)

Mirtazapine withdrawal-induced mania
por: Verma, Jitendra Kumar, et al.
Publicado: (2015)

Tachyphylaxis to the Sedative Action of Mirtazapine
por: Papazisis, Georgios, et al.
Publicado: (2018)

Mirtazapine for the Treatment of Chronic Pruritus
por: Khanna, Raveena, et al.
Publicado: (2019)

Nightmares and Mirtazapine—Time to be vigilant
por: Sudha TY, Sree, et al.
Publicado: (2020)

Mirtazapine overdose is unlikely to cause major toxicity
por: Berling, I., et al.
Publicado: (2014)

PS213. Pharmacokinetics of mirtazapine and its hydroxylated metabolite in Japanese psychiatric patients treated with mirtazapine
por: Watanabe, Takashi, et al.
Publicado: (2016)

Mirtazapine-associated hyponatremia presenting as delirium
por: Ghosh, Abhishek, et al.
Publicado: (2014)

Mirtazapine-induced acute angle closure
por: Kahraman, Nilay, et al.
Publicado: (2015)

Mirtazapine for symptom control in refractory gastroparesis
por: Malamood, Mark, et al.
Publicado: (2017)

Nightmares with mirtazapine - A case report
por: Kavoor, Anjana Rao, et al.
Publicado: (2020)

A Case of Mirtazapine-Induced Pancreatitis
por: Aslam, Hunain, et al.
Publicado: (2023)

Behavioral and Developmental Changes in Rats with Prenatal Exposure of Mirtazapine
por: Sahoo, Jasmita, et al.
Publicado: (2010)

Efficacy and safety of add on low-dose mirtazapine in depression
por: Matreja, Prithpal S., et al.
Publicado: (2012)

Mirtazapine-induced hyperpigmentation with type II histopathologic findings
por: Sukhdeo, Kumar, et al.
Publicado: (2018)

Evaluation of the efficacy of transdermal administration of maropitant in managing vomiting in cats
por: Boukaache, Youcef, et al.
Publicado: (2022)

Mirtazapine-induced psychosis on a young patient with severe malnutrition
por: Sollano, R. T. E., et al.
Publicado: (2023)

Mirtazapine in Paroxetine Induced Hyper-prolactinemic Galactorrhoea
por: Singh, Manjeet, et al.
Publicado: (2015)

Sleep-Related Eating Disorder Associated With Mirtazapine
por: Jeong, Jong-Hyun, et al.
Publicado: (2014)

Mirtazapine Induced Tremors: A Case Report
por: Uvais, N. A., et al.
Publicado: (2019)

Mirtazapine Creating “Miracles” in Psychotic Depression With Catatonia
por: Patel, Rikinkumar S, et al.
Publicado: (2020)

Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection
por: Kikuoka, Ryo, et al.
Publicado: (2020)

Mirtazapine Induced Akathisia: Understanding a Complex Mechanism
por: Raveendranathan, Dhanya, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sonv5nfv7br841udp16dh9ggsi